Invention Grant
- Patent Title: Immunogenic compositions comprising
-
Application No.: US17367812Application Date: 2021-07-06
-
Publication No.: US11897922B2Publication Date: 2024-02-13
- Inventor: Steven G. Reed , Rhea N. Coler , Gregory C. Ireton , Sylvie Bertholet
- Applicant: ACCESS TO ADVANCED HEALTH INSTITUTE
- Applicant Address: US WA Seattle
- Assignee: ACCESS TO ADVANCED HEALTH INSTITUTE
- Current Assignee: ACCESS TO ADVANCED HEALTH INSTITUTE
- Current Assignee Address: US WA Seattle
- Agency: Newport IP, LLC
- Agent Benjamin Keim
- The original application number of the division: US15815512 2017.11.16
- Main IPC: C07K14/35
- IPC: C07K14/35 ; A61K39/04 ; C07K14/285 ; G01N33/569 ; G01N33/68 ; A61K39/00
Abstract:
The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp.) antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.
Public/Granted literature
- US20220017578A1 IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF Public/Granted day:2022-01-20
Information query
